4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-003539
CVP, Chief Financial Officer sold 13,000 shares at an average $84.92 ($1,103,896)
- CVP, Chief Financial Officer acquired 13,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ullem Scott B. · CVP, Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +13,000 | $59.26 | $770,337 | 52,699 | D |
| 2026-03-11 | Sale : show line 2 in the form 10b5-1 | −5,099 | $84.46 | $430,668 | 47,600 | D |
| 2026-03-11 | Sale : show line 3 in the form 10b5-1 | −7,901 | $85.21 | $673,228 | 39,699 | D |
| Open-market sales · 13,000 sh · avg $84.92 · $1,103,896 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-11 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −13,000 | 26,000 | D |
Loading xslF345X05/doc4.xml…